Murphy Capital Management’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q2 | – | Sell |
-2,052
| Closed | -$135K | – | 318 |
|
|
2016
Q1 | $135K | Hold |
2,052
| – | – | 0.02% | 287 |
|
|
2015
Q4 | $127K | Hold |
2,052
| – | – | 0.02% | 306 |
|
|
2015
Q3 | $137K | Hold |
2,052
| – | – | 0.02% | 281 |
|
|
2015
Q2 | $199K | Hold |
2,052
| – | – | 0.03% | 304 |
|
|
2015
Q1 | $191K | Hold |
2,052
| – | – | 0.03% | 315 |
|
|
2014
Q4 | $182K | Hold |
2,052
| – | – | 0.03% | 319 |
|
|
2014
Q3 | $141K | Hold |
2,052
| – | – | 0.02% | 326 |
|
|
2014
Q2 | $117K | Hold |
2,052
| – | – | 0.02% | 329 |
|
|
2014
Q1 | $81K | Hold |
2,052
| – | – | 0.01% | 320 |
|
|
2013
Q4 | $86K | Hold |
2,052
| – | – | 0.01% | 312 |
|
|
2013
Q3 | $61K | Hold |
2,052
| – | – | 0.01% | 300 |
|
|
2013
Q2 | $108K | Buy |
+2,052
| New | +$108K | 0.02% | 287 |
|